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Abstract
 
Initial biologic events that underlie sexual transmission of HIV-1 are poorly understood. To
model these events, we exposed human immature Langerhans cells (LCs) within epithelial tissue
 
explants to two primary and two laboratory-adapted HIV-1 isolates. We detected HIV-1
 
Ba-L
 
 in-
fection in single LCs that spontaneously emigrated from explants by flow cytometry (median of
 
infected LCs 
 
5
 
 0.52%, range 
 
5
 
 0.08–4.77%). HIV-1–infected LCs downregulated surface
CD4 and CD83, whereas MHC class II, CD80, and CD86 were unchanged. For all HIV-1
strains tested, emigrated LCs were critical in establishing high levels of infection (0.1–1 
 
m
 
g
HIV-1 p24 per milliliter) in cocultured autologous or allogeneic T cells. HIV-1
 
Ba-L 
 
(an R5
HIV-1 strain) more efficiently infected LC–T cell cocultures when compared with HIV-1
 
IIIB
 
(an X4 HIV-1 strain). Interestingly, pretreatment of explants with either aminooxypentane-
RANTES (regulated upon activation, normal T cell expressed and secreted) or cellulose acetate
phthalate (potential microbicides) blocked HIV-1 infection of LCs and subsequent T cell infec-
tion in a dose-dependent manner. In summary, we document HIV-1 infection in single LCs af-
ter exposure to virus within epithelial tissue, demonstrate that relatively low numbers of these
cells are capable of inducing high levels of infection in cocultured T cells, and provide a useful
explant model for testing of agents designed to block sexual transmission of HIV-1.
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Introduction
 
Unprotected sexual intercourse is the most common mode
of HIV-1 transmission worldwide (1–3). Many biologic
factors have been implicated in influencing rate of transmis-
sion from individual exposures, including virus strain and
inoculum in semen or vaginal fluid, concomitant ulcerative
anogenital infection, traumatic intercourse, menstrual cy-
cle, and use of oral contraceptives (4–7). In addition, ge-
netic studies have shown that individuals with homozygous
deletions of their CCR5 alleles, the major HIV-1 corecep-
tor used by macrophage-tropic strains of virus (R5 viruses),
are relatively protected from initial HIV-1 infection despite
numerous exposures (8–11). This fact points to the impor-
tance of CCR5 as a critical cofactor involved in sexual
transmission of HIV-1 and also correlates with the finding
that 
 
.
 
90% of HIV-1 strains isolated from patients soon af-
ter primary infection are R5 viruses (12, 13). Given this
finding, potent inhibitors of CCR5, such as aminooxypen-
tane (AOP)
 
1
 
-RANTES (regulated upon activation, normal
T cell expressed and secreted) (14), may eventually prove
useful in blocking sexual transmission of HIV-1.
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Condom use and behavioral interventions have only
been partially successful in slowing the spread of HIV-1 in-
fection. Thus, there is an urgent need for additional inter-
ventions to prevent new HIV-1 infections, including the
development of female-controlled topical formulations of
anti–HIV-1 compounds that could be used as a supposi-
tory, cream, or gel before sexual intercourse (15–19). Ide-
ally, these topical microbicides should be inexpensive, easy
to use, stable under low pH conditions, colorless, tasteless,
and nonirritating to genital mucosal tissues and inactivate a
variety of sexually transmitted microbes within genital se-
cretions and/or block relevant HIV-1 receptors on initial
target cells. To date, the spermicide nonoxynol-9 is the
only compound that has been clinically tested for its ability
to block sexual transmission of HIV-1, but results from this
study were disappointing (20). One promising compound
currently under development, cellulose acetate phthalate
(CAP) (New York Blood Center, New York, NY), is a
component of enteric film coating for tablets and capsules
and has been shown to inactivate HIV-1 and other sexually
transmitted agents in vitro (21, 22), inhibit herpes simplex
type 2 infection in vivo in mice (23), and block vaginal
transmission of SIV in rhesus monkeys (24).
To further understand the pathophysiology of initial
HIV-1 entry and to preclinically test potential topical mi-
crobicides, appropriate models of sexual HIV-1 transmis-
sion are needed. Our previous work in this area has focused
on cell culture models that include Langerhans cells (LCs),
members of the dendritic cell family, because they exhibit
the following characteristics: (a) location within mucosal
epithelium at sites of HIV-1 exposure; (b) expression of
CD4, CCR5, and CXCR4 capable of supporting HIV-1
infection; (c) ability to emigrate to paracortical T cell–rich
areas of regional lymph nodes after contact with virus or
other antigens; and (d) ability to efficiently transmit HIV-1
to cocultured CD4
 
1
 
 T cells during the process of antigen-
specific activation (25–29). No other potential initial target
cell type for HIV-1, including T cells, macrophages, and
epithelial cells, possesses all of these salient features. In this
report, LCs within epithelial tissue explants were infected
with R5, X4, and dual-tropic HIV-1 isolates, and we
tested the ability of two potential microbicides, AOP-
RANTES and CAP, for their ability to block infection.
The strength of this system relies on the use of human epi-
thelium–derived LCs in a relatively “native” state, in that
trypsinization, exogenous cytokine stimulation, and culture
(all capable of altering coreceptor expression and matura-
tion state) were avoided before HIV-1 infection.
 
Materials and Methods
 
Preparation of Epithelial Tissue Explants and CD4
 
1
 
 T Cells.
 
The Institutional Review Board of the National Cancer Institute
approved the suction blistering procedure (30), and informed
consent was obtained from all healthy volunteers. In brief, nor-
mally appearing skin of the anterior thighs was shaved and
cleaned with a povidone-iodine solution followed by 70% etha-
nol. 20 blisters (1 cm in diameter) were then induced by vacuum
 
suction and heat over a 2-h period (see Fig. 1 A). Blister roofs
(i.e., epidermal sheets) were removed with scissors, washed in
three consecutive plastic dishes containing sterile PBS (Biofluids,
Inc.) (see Fig. 1 B), and then used for HIV-1 infection assays. To
show the LC-specific nature of HIV-1 transmission to T cells, in
some experiments single epidermal cell suspensions were made
from explants by limited trypsinization immediately after HIV-1
exposure, and half of the suspensions were depleted of LCs by
immunomagnetic bead selection just before CD4
 
1
 
 T cell cocul-
ture (31).
PBMCs were isolated by density gradient centrifugation from
either heparinized blood of volunteers undergoing suction blis-
tering or from buffy coats of HIV-1–uninfected blood donors.
CD4
 
1
 
 T cell enrichment was performed by negative selection us-
ing a commercially prepared mAb cocktail/complement reagent
(Lympho-Kwik™; One Lambda Inc.) according to manufac-
turer’s guidelines.
 
Viral Strains and Infection Assays. 
 
Purified, pelleted, and ti-
tered HIV-1
 
Ba-L
 
 (R5) (stock at 1.8 
 
3 
 
10
 
10
 
 virus particles per mil-
liliter) and HIV-1
 
IIIB
 
 (X4) (stock at 6.7 
 
3
 
 10
 
10
 
 virus particles per
milliliter) were purchased from Advanced Biotechnologies Inc.
The HIV-1 primary isolates HIV-1
 
CJI.3 
 
(R5) and HIV-1
 
CI-8
 
(R5X4) were gifts of David I. Cohen (Queens College, Flushing,
NY). Predominant coreceptor usage for each strain was deter-
mined using a method as previously described by others (32).
Low passage stocks of these HIV-1 primary isolates were gener-
ated from supernatants of phytohemagglutinin- (PHA; Difco
Laboratories) and IL-2– (Boehringer Mannheim) stimulated PB-
MCs. In brief, PBMCs were cultured at 2 
 
3 
 
10
 
6 
 
cells/ml for 3 d
at 37
 
8
 
C in a humidified 5% CO
 
2
 
 environment in upright flasks
containing RPMI 1640 medium GIBCO BRL), 20% heat-inacti-
vated FBS (GIBCO BRL), 100 U/ml penicillin (GIBCO BRL),
100 
 
m
 
g/ml streptomycin (GIBCO BRL), and 2 mM 
 
l
 
-glu-
tamine (GIBCO BRL) (complete medium) supplemented with
PHA (5 
 
m
 
g/ml). PHA-stimulated PBMCs were then centrifuged
in 15- or 50-ml conical tubes, and cell pellets were resuspended
with low passage cell-free virus (0.1–1 ml of stock per 10
 
7
 
 cells)
and incubated for 1 h at 37
 
8
 
C. After infection, cells were resus-
pended at 10
 
6 
 
cells/ml in complete medium supplemented with
recombinant human IL-2 (20 U/ml) and incubated as above for
an additional 3–10 d (depending on the strain). At the appropriate
time, cultures were centrifuged and supernatants were filtered, al-
iquoted, and frozen at 
 
2
 
70
 
8
 
C. Before use, HIV-1 p24 content of
supernatant stocks, as well as purified laboratory-adapted viral
stocks, was assessed by ELISA (Coulter Corp.) according to the
manufacturer’s instructions.
For infection of epithelial tissue explants, 50-
 
m
 
l droplets con-
taining HIV-1 at various dilutions were placed on the inside sur-
faces of sterile plastic culture dish covers (see Fig. 1 C). In all ex-
periments with primary HIV-1 isolates, explants were exposed to
stock supernatants containing 50–200 ng of HIV-1 p24 protein.
Explants were either draped over droplets with the basal epithe-
lial cell surface or the stratum corneum surface facing downward
(see Fig. 1, D and E). Virus and explants were incubated together
in this manner at 37
 
8
 
C in a humidified 5% CO
 
2
 
 environment for
2 h. Explants were washed in three separate wells in 6-well plates
containing sterile PBS and then floated with the basal epithelial
cell sides down in 12-well plates containing 2 ml of complete
medium (as above, except that FBS was replaced with 20% hu-
man AB serum (Sigma-Aldrich), without exogenous stimulants
or cytokines (see Fig. 1 F). For some experiments, floating ex-
plants were cocultured with 2 
 
3
 
 10
 
6
 
 resting autologous or alloge-
neic CD4
 
1
 
 T cells (10
 
6 
 
cells/ml); for these experiments, explants 
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were removed from cultures after 2 d and discarded. To show
that HIV-1 p24
 
1
 
 LCs had true intracellular HIV-1 infection (as
opposed to positive staining due to extracellular bound virus), in
some experiments “crawl-out” LCs collected from media 2 d af-
ter HIV-1 exposure of explants were collected, and half of the
cells were exposed to 0.1% trypsin for 10 min at 37
 
8
 
C to remove
extracellular bound virus. Trypsin-treated and untreated LCs
were then cocultured with CD4
 
1
 
 T cells.
 
Assessment of LC and LC–T Cell Infection by HIV-1. 
 
HIV-1
infections in LC and LC–T cell populations were assessed by
flow cytometry for intracellular HIV-1 p24 protein, ELISA for
HIV-1 p24 protein levels in culture supernatants, and transmis-
sion electron microscopy for visualization of virions. To deter-
mine the sensitivity of the flow cytometric analyses, we mixed
varying numbers of HIV-1–infected H9 cells (a gift from R.
Yarchoan, NCI, Bethesda, MD) with uninfected H9 cells,
stained these cell mixtures for intracellular HIV-1 p24 (see be-
low), and determined the percentage of infected cells by flow
cytometry. For the explant experiments, LCs that had emigrated
from tissue into media 2–4 d after HIV-1 exposure of explants
were collected, passed through a 70-
 
m
 
m mesh, washed three
times in 2% human AB serum/PBS (staining buffer), preincu-
bated in staining buffer for 10 min at room temperature to block
nonspecific staining, and then incubated with 10 
 
m
 
g/ml PE-
conjugated mouse anti–human mAbs for 30 min at 4
 
8
 
C. Specifi-
cally, we used anti-MHC class I and II, CD80, CD86, CD4,
CD83, or isotype control mAbs to label surface antigens on LCs
(all from PharMingen). Cells were then washed three times in
staining buffer, incubated with Dead Red (Molecular Probes,
Inc.) for 20 min at room temperature to label dead cells, washed
three times in staining buffer, and fixed and permeabilized with
Cytofix/Cytoperm reagents (PharMingen) for 20 min at 4
 
8
 
C.
Cells were then washed three times in PermWash (PharMin-
gen), incubated with 10 
 
m
 
g/ml unconjugated rat anti–HIV-1
p24 IgG (Biosource International) diluted in Perm/Wash for 30
min at 4
 
8
 
C, washed three times in PermWash, and finally incu-
bated with FITC-conjugated goat anti–rat F(ab
 
9
 
)
 
2
 
 (Biosource In-
ternational) for 30 min at 4
 
8
 
C. Cells were then washed and
examined by flow cytometry using a FACScan
 
®
 
 (Becton Dickin-
son) equipped with Lysis™ II software (Becton Dickinson).
Dead cells, i.e., Dead Red–positive cells, were excluded from all
analyses.
For detection of secreted HIV-1 p24 protein, supernatants
were harvested every other day from cocultures of emigrated LCs
and CD4
 
1
 
 T cells, inactivated with 2% (vol/vol) Triton X-100
(Sigma-Aldrich) in PBS and frozen at 
 
2
 
20
 
8
 
C. After collecting
supernatants for 2–3 wk, samples were thawed and examined for
HIV-1 p24 protein content by ELISA.
To specifically identify individually infected cells by transmis-
sion electron microscopy, LCs migrating from explants in the ab-
sence of cocultured T cells were collected 2–3 d after infection of
explants. In addition, LCs and T cells were collected 4 and 7 d af-
ter infection of explants. Harvested cells were fixed overnight in
neutral buffered 2.5% (vol/vol) glutaraldehyde, postfixed in 1%
OsO
 
4
 
, dehydrated in graded ethanol and propylene oxide, and
embedded in Spurr’s epoxy. Thin sections were stained with ura-
nyl acetate and lead citrate and examined for the presence and lo-
cation of budding and mature HIV-1 virions using a Zeiss EM10
electron microscope at 60 kV.
 
Evaluation of Potential Microbicides. 
 
AOP-RANTES and CAP
were evaluated for their ability to block HIV-1 infection of LCs
within explants at doses of 1, 10, and 100 nM (for AOP-
RANTES) and 0.5, 1, 5, and 10 mg/ml (for CAP). AOP-
 
RANTES was dissolved in PBS, whereas CAP was dissolved in
0.3 M sodium acetate, pH 5.5. Hydroxypropylmethylcellulose
dissolved in 0.3 M sodium acetate and 0.3 M sodium acetate
alone were used as controls for CAP because they demonstrated
similar viscosity and pH to CAP/sodium acetate, respectively.
Notably, a 140 mg/ml gel formulation of CAP has been tested as
a microbicide in SIV-macaque studies monkeys (24). 50-
 
m
 
l drop-
lets containing drug at various concentrations were placed on the
inside surface of sterile plastic culture dish covers (see Fig. 1 C),
and explants were draped over droplets with the basal epithelial
cell layer down (see Fig. 1, D and E) for 20 min at 37
 
8
 
C; 50 
 
m
 
l of
virus at various dilutions was then added to drug under the ex-
plants and incubated for an additional 2 h at 37
 
8
 
C. Drug and virus
were then washed from explants in three separate dishes contain-
ing sterile PBS and floated in complete medium with the basal
epithelial cell layer down (see Fig. 1 F), with or without underly-
ing CD4
 
1
 
 T cells. Notably, no exogenous drugs or virus were
added during the subsequent coculture of HIV-1–exposed ex-
plants and CD4
 
1
 
 T cells. 
 
Results
 
HIV-1 Infects LCs within Epithelial Tissue Explants. 
 
It is
known that LCs within peripheral epithelial tissues are in a
relatively immature or resting state (25, 26). To mimic
conditions present after mucosal exposure to HIV-1, we
obtained epithelial tissue containing immature LCs by suc-
tion blistering of healthy human skin. This procedure splits
skin through the lamina lucida, leaving the blister roof (i.e.,
the epidermis) histologically intact and devoid of subepi-
thelial cells, including T cells (data not shown). Epithelial
tissue explants were cocultured with HIV-1, washed three
times in PBS to remove excess virus, and floated in com-
plete medium with the basal epithelial sides of the tissues
facing downward (Fig. 1). LCs spontaneously emigrated
from epithelial tissues into surrounding media over the fol-
lowing 1–4 d. From one epithelial tissue explant 1 cm in
diameter, 
 
z
 
2 
 
3
 
 10
 
4
 
 LCs could be collected from media af-
ter floating for 3 or 4 d. There were more keratinocytes in
cell populations collected at days 3 and 4 compared with
cell populations collected on days 1 and 2.
Using mixed populations containing known amounts of
HIV-1–infected and uninfected H9 cells, we determined
the sensitivity to detect HIV-1–infected cells by flow cy-
tometry to be 0.01% (data not shown). Using this assay, we
were able to readily and reproducibly document HIV-1 in-
fection in single LCs (Fig. 2). Specifically, HIV-1
 
Ba-L 
 
infec-
tion was detected in “crawl-out” LCs collected 3 d after
HIV-1 exposure of explants in 
 
.
 
30 experiments (median
percentage HIV-1 p24
 
1
 
 LCs 
 
5 
 
0.52%, 25% quartile 
 
5
 
0.33%, 75% quartile 
 
5
 
 0.87, range 
 
5
 
 0.08–4.77%,
 
 n 
 
= 31;
Fig. 2). Isotype control Ab staining of HIV-1–infected LCs
was always negative, whereas uninfected LCs stained with
anti–HIV-1 p24 mAb showed occasional low positive
staining (median 
 
5
 
 0.01%, 25% quartile 
 
5
 
 0%, 75% quar-
tile 
 
5
 
 0.13%, range 
 
5
 
 0–0.23%,
 
 n 
 
= 31), confirming the
specificity of the HIV-1 p24 staining (Fig. 2). For each
FACS
 
®
 
 experiment, this latter background staining was al-
ways subtracted from the specific staining values to gener- 
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ate the “true” numbers of HIV-1 p24
 
1
 
 LCs shown in Fig.
2 C. No other cell types present within crawl-out cell
preparations (mostly keratinocytes) showed p24 positivity
(data not shown). In addition, we routinely checked for
p24
 
1
 
CD3
 
1
 
 T cells within crawl-out populations, but these
were never detected (data not shown). Notably, we were
unable to reproducibly detect HIV-1 p24
 
1
 
 LCs by FACS
 
®
 
analyses when using HIV-1 isolates other then HIV-1
 
Ba-L
 
,
probably due to low levels of HIV-1 infection that ap-
proach the sensitivity of this assay (i.e., 0.01%). However,
we have been able to detect proviral DNA in crawl-out
LCs exposed to these isolates in preliminary PCR experi-
ments, including in LCs exposed to the X4 HIV-1 isolate
HIV
 
IIIB
 
 (data not shown).
 
HIV-1 virions could not be visualized in LCs using elec-
tron microscopy (data not shown), probably due to the low
sensitivity of this method to detect relatively few produc-
tively infected cells.
 
Number and Phenotype of HIV-1-Infected LCs. 
 
When
purified laboratory-adapted HIV-1 was used to infect LCs,
the number of crawl-out LCs per epithelial sheet exposed
to HIV-1 was approximately equal to the number LCs per
epithelial sheet not exposed to HIV-1 (2 
 
3
 
 10
 
4
 
 LCs per
epithelial sheet). However, when using primary isolates of
HIV-1, there were approximately two- to threefold greater
numbers of LCs that migrated from HIV-1–exposed epi-
thelial sheets when compared with LCs collected from un-
exposed epithelial sheets. This, however, could have been
Figure 2. HIV-1 infection of single
crawl-out LC demonstrated by flow
cytometry. Representative intracellular
HIV-1 p24 and surface MHC class II
mAb double-staining of LCs that have
emigrated from HIV-1Ba-L–exposed (A
and C) or uninfected (B) epithelial tis-
sue explants, demonstrating 0.85%
productively infected cells in A and
low nonspecific staining in B. Dead
cells were excluded from all analyses.
HIV-1–infected cells stained with an
isotype control Ab were always nega-
tive (data not shown). (C) Plot of per-
centage of HIV-1 p241 LCs (with
background staining subtracted) ob-
tained in 31 separate experiments
showing the range of intracellular
HIV-1 p24 positivity depending on
the skin donor.
Figure 1. Experimental set-up for infecting LCs within epithelial tissue explants and for evaluating potential microbicides. (A) Suction blisters. (B)
Blister roofs, i.e., epithelial tissue explants, floating in PBS after surgical removal. (C) 50-ml droplets containing HIV-1 before LC infection (droplets con-
taining drugs in the microbicide experiments appeared identical). (D and E) Epithelial tissue explants being draped over HIV-1 droplets. (F) Epithelial tis-
sue explants floating in complete medium after HIV-1 infection. The pictures shown are representative of a typical experiment.1495 Kawamura et al.
due to LC exposure to cytokines present in the primary
isolate viral preparations (that were not present in the labo-
ratory-adapted viral preparations).
We next examined the phenotype of HIV-1 p241 LCs
by two-color flow cytometry. HIV-1 p241 LCs expressed
equal amounts of cell surface MHC class II, CD80, and
CD86 when compared with HIV-1 p242 LCs (Fig. 3).
However, cell surface CD4 and CD83 were clearly down-
regulated on HIV-1–infected LCs when compared with
uninfected LCs (Fig. 3). This particular pattern of staining
(no change in MHC class II, CD80, and CD86 with
downregulation of CD4, and CD83) is similar to what we
have recently observed on HIV-1 p241 monocyte-derived
dendritic cells (Kawamura, T., and A. Blauvelt, manuscript
in preparation).
HIV-1–infected LCs That Have Emigrated from Epithelial
Tissue Explants Transmit Virus to Cocultured Allogeneic or Au-
tologous CD41 T Cells.  We next cocultured crawl-out
LCs with T cells in an approximate LC/T cell ratio of 1:100
(2 3 104 LCs per 2 3 106 T cells). Although only relatively
few productively infected LCs could be identified in
crawl-out populations (Fig. 2), these cells could induce
high levels of HIV-1 infection in cocultured T cells (Figs.
4–7). LCs could transmit both primary and laboratory-
adapted HIV-1 isolates to T cells (Figs. 4–7). Notably, lev-
els of HIV-1 infection in cocultured T cells were similar
when either the stratum corneum surfaces or the basal epi-
thelial surfaces were exposed to virus (Fig. 4). Interest-
ingly, electron microscopy of LC–T cell cocultures 4 and
7 d after HIV-1 exposure of epithelial tissue explants re-
vealed numerous virions budding from the surfaces of T
cells, but not LCs (Fig. 4 B). T cell infection, as localized
by electron microscopy and quantitated by p24 superna-
tant levels, was critically dependent on HIV-1–infected
LCs, as evidenced by the following: (a) LC-depleted epi-
dermal cell suspensions made from HIV-1–exposed epi-
thelial tissue explants failed to transmit infection to cocul-
tured T cells (Fig. 4) and (b) HIV-1–infected crawl-out
LCs exposed briefly to trypsin (which effectively cleaved
off any extracellular bound HIV-1 virions) (33) transmit-
Figure 3. Downregulation of CD4 and CD83 on HIV-1–infected
LCs. LCs that had emigrated from HIV-1Ba-L–exposed skin were double
stained for the surface antigens shown and intracellular HIV-1 p24. Dead
cells were excluded from all analyses. Data shown are representative of at
least three experiments.
Figure 4. HIV-1–infected LCs are responsible for transmitting
high levels of infection to cocultured CD41 T cells. (A, top left)
Tissue explants were exposed to two HIV-1 primary isolates,
HIV-1CJI.3 (R5) or HIV-1CI-8 (R5X4), on the basal epithelial (BE)
side or the stratum corneum (SC) side, washed, and then floated
in media containing allogeneic CD41 T cells. (B) electron micro-
graph taken from an LC–T cell coculture 7 d after HIV-1CI-8 ex-
posure of explants showing numerous HIV-1 virions surrounding
and budding from a CD41 T cell (364,000; inset 3440,000). (A,
bottom left) Epidermal cell suspensions were made immediately
after HIV-1 exposure of epithelial tissue explants to HIV-1CJI.3,
and half of the suspensions were then depleted of LCs by immu-
nomagnetic bead separation. Nondepleted epidermal cells (EC)
and LC-depleted epidermal cells (EC-LC) were then cocultured
with allogeneic CD41 T cells. (A, bottom right) Emigrated LCs were collected from media 2 d after HIV-1CJI.3 exposure of epithelial tissue explants, and
half of the cells were exposed to trypsin treatment and the other half left untreated. Trypsin-treated LCs and untreated LCs were then cocultured with al-
logeneic CD41 T cells. HIV-1 infection levels were assessed by measuring HIV-1 p24 protein content by ELISA in coculture supernatants collected ev-
ery other day (A, all panels). Data shown are representative of at least three separate experiments that showed similar results.1496 Microbicides Block HIV Infection of Langerhans Cells within Tissue
ted infection to cocultured T cells as well as infected LCs
not exposed to trypsin (Fig. 4). Importantly, these two
types of experiments rule out the possibility that free HIV-1
virions nonspecifically adhered to epithelial cells and were
passively transferred to T cells.
To compare efficiency of R5 virus infection to X4 virus
infection, LCs within tissue explants were exposed to
known amounts (as determined by HIV-1 p24 content) of
either the laboratory-adapted R5 isolate HIV-1Ba-L or the
laboratory-adapted X4 isolate HIV-1IIIB. Because these vi-
ruses were grown in different cell types, TCID50 values
were not directly comparable. We chose what we believed
to be the next best measure, HIV-1 p24 content, to nor-
malize virus input. Using this method of normalization, the
X4 virus HIV-1IIIB was clearly transmitted less well when
compared with infection with the R5 virus HIV-1Ba-L (Fig.
5). This difference was even more dramatic when crawl-
out LCs were cocultured with autologous T cells (Fig. 5 C)
instead of allogeneic T cells (Fig. 5). These data are consis-
tent with the HIV coreceptor phenotype that we have
documented on immature and mature LCs (34, 35).
AOP-RANTES and CAP Each Block HIV-1 Infection of
LCs and Subsequent Infection of CD41 T Cells.  To test
whether our new explant model system could be useful as
a preclinical method to screen potential microbicides, epi-
thelial sheets were incubated with the compounds AOP-
RANTES or CAP for 20 min prior to HIV-1 infection.
Preincubation with AOP-RANTES, a synthetic chemo-
kine analogue of RANTES that binds to CCR5 (14),
blocked R5 HIV-1 infection of LCs in a dose-dependent
manner (Fig. 6 A). Subsequent R5 HIV-1 infection in
LC–T cell cocultures was also blocked in a dose-depen-
dent manner (Fig. 6, B and C), but not subsequent infec-
tion with the X4 virus HIV-1IIIB (Fig. 6 D). AOP-
RANTES blocked infection of both laboratory-adapted
and primary isolate R5 viruses. This data demonstrates the
specificity of the blocking effect of AOP-RANTES and
shows that coreceptor usage is important for LC infection.
Preincubation of epithelial sheets with AOP-RANTES
did not cause cell toxicity or changes in the number of
emigrated LCs at the doses used in this study (data not
shown).
Figure 5. Preferential infection of HIV-
1Ba-L in LC–T cell cocultures when com-
pared directly with HIV-1IIIB. Known
amounts, as determined by HIV-1 p24 con-
tent, of HIV-1Ba-L (an R5 virus) and HIV-
1IIIB (an X4 virus) were incubated with epi-
thelial tissue explants, washed, and floated in
media containing either allogeneic (A–C) or
autologous (C) CD41 T cells. For data
shown in C, high titers (1:100 for HIV-1Ba-L
and 1:15 for HIV-1IIIB) of each HIV-1 strain
were used for infection. Infection levels
were assessed by measuring HIV-1 p24 pro-
tein content by ELISA in coculture superna-
tants collected every other day. Data shown
are representative of at least three separate
experiments that showed similar results.
Figure 6.  Preincubation of epithelial
tissue explants with AOP-RANTES
specifically blocks subsequent HIV-1Ba-L
and HIVCJ1.3, but not HIV-1IIIB, infec-
tion in LC and LC–T cell cocultures in
a dose-dependent manner. Epithelial tis-
sue explants were incubated with 1, 10,
or 100 nM of AOP-RANTES, a CCR5
ligand, for 20 min before exposure to
1:100 HIV-1Ba-L (A and B) or HIVCJ1.3
(C), both R5 viruses, or 1:15 HIV-1IIIB
(D), an X4 virus. After infection, ex-
plants were washed and floated in media
alone (A) or in media containing alloge-
neic CD41 T cells (B–D). HIV-1 infec-
tion levels were assessed by intracellular
HIV-1 p24 staining (A) or by measuring
HIV-1 p24 protein content by ELISA in
coculture supernatants collected every
other day (B–D). Data shown are repre-
sentative of at least three separate exper-
iments that showed similar results.1497 Kawamura et al.
Preincubation with CAP, a compound used for enteric
coating of tablets and capsules (21–23), also blocked infec-
tion of LCs (Fig. 7 A) as well as subsequent infection
in LC–T cell cocultures (Fig. 7, B and C). As with
AOP-RANTES, CAP demonstrated clear dose-dependent
blocking effects. Both laboratory-adapted and primary iso-
lates, as well as both R5 and X4 viruses, were blocked by
CAP. Preincubation of epithelial sheets with CAP did not
lead to cell toxicity nor changes in the number of emi-
grated LCs at the doses used in this study (data not shown).
Discussion
We believe that tissue culture models for sexual trans-
mission of HIV-1 should focus on LCs, members of the
dendritic cell family, because LCs represent the most likely
initial targets for HIV-1. LCs reside in mucosal surfaces at
sites of HIV-1 exposure, express CD4 and HIV-1 corecep-
tors, have been shown to be infectable with HIV-1 in vivo
and in vitro, are capable of emigrating to lymph nodes, and
are efficient at transmitting virus to CD41 T cells (25–29).
Despite this, two recently published explant models have
failed to sufficiently evaluate the role of LCs in genital tis-
sue infection by HIV-1 (36, 37). Understandably, several
problems are inherent in working with LCs under experi-
mental conditions. Isolation of true tissue LCs is laborious
because it is difficult to obtain large numbers of relatively
pure cell populations. Most problematic, however, is that
standard isolation procedures require trypsinization of epi-
thelial tissues and/or a culture period to collect single-cell
suspensions of LCs (31, 34, 35, 38, 39). Use of trypsin in-
terferes with subsequent HIV-1 infection experiments be-
cause it cleaves CD4 that is required for virus entry into
LCs (33). Culturing epithelial tissues to obtain crawl-out
LCs avoids trypsin, although this procedure dramatically
changes the phenotype and function of LCs (40). More
specifically, freshly isolated LCs, which resemble LCs in
situ, express surface CCR5 and no surface CXCR4,
whereas crawl-out LCs and LCs cultured for as few as 16 h
resemble mature dendritic cells; these cells express CXCR4
and comparatively low levels of surface CCR5 (34, 35, 41).
In this report, these problems are avoided by exposing LCs
to HIV-1 as they reside within epithelial tissue (Fig. 1).
Thus, this model is likely to mimic biologic conditions
present during sexual transmission of HIV-1.
Like our model, Reece et al. recently reported on the
use of skin to model early events of HIV-1 transmission
(38). These investigators used abraded surgical skin speci-
mens and were able to show selective infection by R5 vi-
ruses when compared with X4 viruses using a PCR-based
assay. Unlike this previously published study, abrasion of
epidermis was not necessary for LC infection to occur
through stratum corneum surfaces in our model system
(Fig. 4). We postulate that either the stratum corneum was
not acting as an effective barrier to infection or that virus
was gaining access to LCs by infecting these cells through
small breaks in the stratum corneum or through the lateral
aspects of the tissue. In addition, and something not dem-
onstrated in the Reece study, we were able to document
infection in single LCs by intracellular staining for HIV-1
p24 protein (Fig. 2), utilize this technique to phenotype
HIV-1-infected LCs (Fig. 3), and demonstrate that poten-
tial microbicides could block LC infection (Figs. 6 and 7).
Interestingly, CD4 and CD83 were downregulated on the
surfaces of HIV-1 p241 LCs, whereas MHC class II,
CD80, and CD86 were unchanged. To our knowledge,
this represents the first study to document the phenotype of
HIV-1 infected LCs, although the functional significance
of these phenotypic changes remains to be determined. A
recent study has demonstrated downregulation of CD83
Figure 7. Preincubation of epithelial tissue explants with
CAP blocks subsequent HIV-1 infection in LC and LC–T cell
cocultures in a dose-dependent manner. Epithelial tissue ex-
plants were incubated with 1 or 10 mg/ml of CAP, a candi-
date microbicide, for 20 min before exposure to HIV-1. After
infection, explants were washed and floated in media alone (A)
or in media containing allogeneic CD41 T cells (B and C).
HIV-1 infection levels were assessed by intracellular HIV-1
p24 staining (A) or by measuring HIV-1 p24 protein content
by ELISA in coculture supernatants collected every other day
(B and C). Data shown are representative of at least three sep-
arate experiments that showed similar results.1498 Microbicides Block HIV Infection of Langerhans Cells within Tissue
and functional impairment in dendritic cells infected with
herpes simplex virus type 1 (42).
Similar to the Reece study (38), R5 viral infection was
much more efficient than X4 virus infection in the system
described here, although this selection was not absolute
(Fig. 5). Additionally, our model suggests that use of autol-
ogous instead of allogeneic T cells in LC–T cell cocultures
contributes to relative selection of R5 virus infection. This
finding is consistent with data from others suggesting that
resting or nonproliferating T cells may preferentially repli-
cate R5 viruses in the setting of dendritic cell–T cell clus-
tering (43, 44). Thus, we propose that both differential
HIV-1 coreceptor expression on resident LCs (34) and the
ability of autologous T cells to preferentially replicate R5
viruses that are transmitted by HIV-1–infected LCs con-
tribute to preferential infection by R5 viruses during sexual
transmission of HIV-1 (12, 13).
One difficulty in firmly establishing a role for LCs in ini-
tial HIV-1 infection has been the interpretation of results
obtained in SIV-macaque studies. When mucosal tissues
have been examined after atraumatic cell-free SIV inocula-
tion, most studies have shown no evidence of intraepithe-
lial LC infection (43, 45, 46). However, virus-infected LCs
would be expected to emigrate from epithelium within a
few hours after exposure, so that tissue from time points
earlier than 24 h after inoculation would need to be exam-
ined to document infection within intraepithelial LCs. Sec-
ond, assays that detect only productive HIV-1 infection
within tissue, e.g., HIV-1 p24 staining, would be expected
to show negative staining in HIV-1–exposed activated LCs.
This assumption is based on the in vitro findings that im-
mature dendritic cells can be productively infected with
HIV-1 but that initiation of the activation process rapidly
leads to nonproductive latent HIV-1 infection within ma-
ture dendritic cells (39, 47, 48). Interestingly, Hu et al.
have recently documented SIV-infected LCs within mu-
cosal epithelium 18 h after vaginal exposure to virus (49).
Thus, proving a definitive role for LCs in initial HIV-1/
SIV infection requires specialized technical expertise. Here,
in a novel ex vivo model that is consistent with the results
of Hu et al. (49), we show definitive evidence that HIV-1–
infected LCs are critically involved in the subsequent trans-
mission of virus to T cells (Fig. 4). Interestingly, relatively
few HIV-1–infected LCs (usually ,1%) were capable of
inducing high levels of infection in cocultured T cells
(0.1–1  mg HIV-1 p24 per milliliter).
Faced with the daunting task of controlling sexual spread
of HIV-1 around the world, many investigators and drug
companies have focused on developing topical barrier
compounds to prevent new infections (15–19). Several of
these compounds have been shown to be safe and are now
being tested in clinical settings to determine efficacy in
blocking HIV-1 transmission. These microbicides, as well
as newer potential microbicides, are screened in the labora-
tory with a CD4- and HIV-1 coreceptor–independent as-
say that involves HIV-1 infection of a transformed cervical
epithelial cell line (50); however, the relevance of this assay
to sexual transmission of HIV-1 is unclear. In addition,
more newly described explant models fail to elucidate a
role for LCs in genital tissue HIV-1 infection (36, 37).
Thus, essentially no current tissue culture model appears to
be adequate for preclinical testing of these agents. Impor-
tantly, the LC infection model described in this report pro-
vides a physiologic system to evaluate potential microbi-
cides in the laboratory. We demonstrate the usefulness of
this approach by showing that AOP-RANTES and CAP,
two potential microbicides currently under investigation,
can block both LC infection and LC-mediated infection of
T cells (Figs. 6 and 7). Furthermore, it is possible that this
model system could be adapted to study transmission char-
acteristics of other sexually transmitted pathogens. In this
regard, Wu et al. have recently reported on dengue virus
infection of cutaneous dendritic cells that had emigrated
from virus-exposed skin explants (51).
In summary, we describe a novel, physiologically rele-
vant ex vivo model for sexual transmission of HIV-1 that
takes advantage of the biologic properties of LCs, likely ini-
tial targets for HIV-1 after mucosal exposure to virus. We
have used this model to document infection of LCs on a
single-cell level and to show that two candidate microbi-
cides are capable of blocking LC infection and subsequent
transmission of virus to T cells. Our system should prove
valuable in further understanding early cellular and molec-
ular events involved in primary HIV-1 infection and in the
preclinical testing of additional agents designed to block
mucosal transmission of virus.
We thank David I. Cohen for primary HIV-1 isolates and corecep-
tor usage assay, Inga Tokar, Ana Hancox, and Laura Musse for as-
sisting with healthy volunteers, Harry Schaefer for preparing fig-
ures, and Mark C. Udey, Stephen I. Katz, and Roberta J. Black for
helpful discussions.
Submitted: 21 July 2000
Revised: 28 September 2000
Accepted: 6 October 2000
References
1. Royce, R.A., A. Sena, W. Cates, and M.S. Cohen. 1997.
Sexual transmission of HIV. N. Engl. J. Med. 336:1072–1078.
2. Kahn, J.O., and B.D. Walker. 1998. Acute human immuno-
deficiency virus type 1 infection. N. Engl. J. Med. 339:33–39.
3. Fauci, A.S. 1999. The AIDS epidemic-considerations for the
21st century. N. Engl. J. Med. 341:1046–1050.
4. Cohen, M.S. 1998. Sexually transmitted diseases enhance
HIV transmission: no longer a hypothesis. Lancet. 351:5–7
(Suppl.). 
5. Vernazza, P.L., J.J. Eron, S.A. Fiscus, and M.S. Cohen. 1999.
Sexual transmission of HIV: infectiousness and prevention.
AIDS. 13:155–166.
6. Cohen, O.J., and A.S. Fauci. 1998. Host factors that affect
sexual transmission of HIV. Int. J. Infect. Dis. 2:182–185.
7. Miller, C.J. 1998. Host and viral factors influencing hetero-
sexual HIV transmission. Rev. Reprod. 3:42–51.
8. Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W.
Smith, R. Allikmets, J.J. Goedert, S.P. Buchbinder, E. Vit-
tinghoff, E. Gomperts, et al. 1996. Genetic restriction of
HIV-1 infection and progression to AIDS by a deletion allele1499 Kawamura et al.
of the CKR5 structural gene. Science. 273:1856–1862.
9. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard,
C.M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C.
Forceille, et al. 1996. Resistance to HIV-1 infection in Cau-
casian individuals bearing mutant alleles of the CCR-5
chemokine receptor gene. Nature. 382:722–725.
10. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin,
R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup,
and N.R. Landau. 1996. Homozygous defect in HIV-1 core-
ceptor accounts for resistance of some multiply-exposed indi-
viduals to HIV-1 infection. Cell. 86:367–377.
11. Huang, Y., W.A. Paxton, S.M. Wolinsky, A.U. Neumann,
L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdan-
bakhsh, et al. 1996. The role of a mutant CCR5 allele in
HIV-1 transmission and disease progression. Nat. Med. 2:
1240–1243.
12. Zhang, L.Q., P. MacKenzie, A. Cleland, E.C. Holmes, H.J.
Brown, and P. Simmonds. 1993. Selection for specific se-
quences in the external envelope protein of human immuno-
deficiency virus type 1 upon primary infection. J. Virol. 67:
3345–3356.
13. Zhu, T., H. Mo, N. Wang, D.S. Nam, Y. Cao, R.A. Koup,
and D.D. Ho. 1993. Genotypic and phenotypic characteriza-
tion of HIV-1 patients with primary infection. Science. 261:
1179–1181.
14. Simmons, G., P.R. Clapham, L. Picard, R.E. Offord, M.M.
Rosenkilde, T.W. Schwartz, R. Buser, T.N.C. Wells, and
A.E. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity
in macrophages and lymphocytes by a novel CCR5 antago-
nist. Science. 276:276–279.
15. Elias, C.J., and C. Coggins. 1996. Female-controlled meth-
ods to prevent sexual transmission of HIV. AIDS. 10:S43–51
(Suppl.).
16. Pauwels, R., and E. De Clercq. 1996. Development of vagi-
nal microbicides for the prevention of heterosexual transmis-
sion of HIV. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.
11:211–221.
17. Rosenthal, S.L., S.S. Cohen, and L.R. Stanberry. 1998. Top-
ical microbicides. Current status and research considerations
for adolescent girls. Sex. Transm. Dis. 25:368–377.
18. Gross, M., S.P. Buchbinder, C. Celum, P. Heagerty, and
G.R. Seage, 3rd. 1998. Rectal microbicides for U.S. gay
men. Are clinical trials needed? Are they feasible? HIVNET
Vaccine Preparedness Study Protocol Team. Sex. Transm.
Dis. 25:296–302.
19. Wainberg, M.A. 1999. The need for microbicides: why
aren’t women’s groups more involved in the fight against
AIDS?  AIDS Res. Hum. Retroviruses. 15:405–406.
20. Roddy, R.E., L. Zekeng, K.A. Ryan, U. Tamoufe, S.S.
Weir, and E.L. Wong. 1998. A controlled trial of nonoxynol
9 film to reduce male-to-female transmission of sexually
transmitted diseases. N. Engl. J. Med. 339:504–510.
21. Neurath, A.R., N. Strick, Y.Y. Li, K. Lin, and S. Jiang.
1999. Design of a “microbicide” for prevention of sexually
transmitted diseases using “inactive” pharmaceutical excipi-
ents. Biologicals. 27:11–21.
22. Neurath, A.R., Y.Y. Li, R. Mandeville, and L. Richard.
2000. In vitro activity of a cellulose acetate phthalate topical
cream against organisms associated with bacterial vaginosis. J.
Antimicrob. Chemother. 45:713–714.
23. Gyotoku, T., L. Aurelian, and A.R. Neurath. 1999. Cellu-
lose acetate phthalate (CAP): an “inactive” pharmaceutical
excipient with antiviral activity in the mouse model of genital
herpesvirus infection. Antiviral Chem. Chemother. 10:327–
332.
24. Manson, K.H., M.S. Wyand, C. Miller, and A.R. Neurath.
2000. Effect of a cellulose acetate phthalate topical cream on
vaginal transmission of simian immunodeficiency virus in
rhesus monkeys. Antimicrob. Agents Chemother. 44:3199–
3202.
25. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells
and the control of immunity. Nature. 392:245–252.
26. Jakob, T., and M.C. Udey. 1999. Epidermal Langerhans
cells: from neurons to nature’s adjuvants. Adv. Dermatol. 14:
209–259.
27. Weissman, D., and A.S. Fauci. 1997. Role of dendritic cells
in immunopathogenesis of human immunodeficiency virus
infection. Clin. Microbiol. Rev. 10:358–367.
28. Zoeteweij, J.P., and A. Blauvelt. 1998. HIV-dendritic cell in-
teractions promote efficient viral infection of T cells. J.
Biomed. Sci. 5:253–259.
29. Cameron, P., M. Pope, A. Granelli-Piperno, and R.M.
Steinman. 1996. Dendritic cells and the replication of HIV-1.
J. Leukoc. Biol. 59:158–171.
30. Cooper, K.D., G.R. Neises, and S.I. Katz. 1986. Antigen-
presenting OKM51 melanophages appear in human epider-
mis after ultraviolet radiation. J. Invest. Dermatol. 86:363–370.
31. Blauvelt, A., H. Asada, V. Klaus-Kovtun, D.J. Altman, D.R.
Lucey, and S.I. Katz. 1996. Interleukin-15 mRNA is ex-
pressed by human keratinocytes, Langerhans cells, and blood-
derived dendritic cells and is downregulated by ultraviolet B
radiation. J. Invest. Dermatol. 106:1047–1052.
32. Deng, H.K., D. Unutmaz, V.N. Kewal-Ramani, and D.R.
Littman. 1997. Expression cloning of new receptors used by
simian and human immunodeficiency viruses. Nature. 388:
296–300.
33. Tang, S., and J.A. Levy. 1991. Inactivation of HIV-1 by
trypsin and its use in demonstrating specific virus infection of
cells. J. Virol. Methods. 33:39–46.
34. Zaitseva, M., A. Blauvelt, S. Lee, C.K. Lapham, V. Klaus-
Kovtun, H. Mostowski, J. Manischewitz, and H. Golding.
1997. Expression and function of CCR5 and CXCR4 on
human Langerhans cells and macrophages: implications for
HIV primary infection. Nat. Med. 3:1369–1375.
35. Zoeteweij, J.P., H. Golding, H. Mostowski, and A. Blauvelt.
1998. Cutting edge: cytokines regulate expression and func-
tion of the HIV coreceptor CXCR4 on human mature den-
dritic cells. J. Immunol. 161:3219–3223.
36. Collins, K.B., B.K. Patterson, G.J. Naus, D.V. Landers, and
P. Gupta. 2000. Development of an in vitro organ culture
model to study transmission of HIV-1 in the female genital
tract. Nat. Med. 6:475–479.
37. Greenhead, P., P. Hayes, P.S. Watts, K.G. Laing, G.E. Grif-
fin, and R.J. Shattock. 2000. Parameters of human immuno-
deficiency virus infection of human cervical tissue and inhibi-
tion by vaginal virucides. J. Virol. 74:5577–5586.
38. Reece, J.C., A.J. Handley, E.J. Anstee, W.A. Morrison, S.M.
Crowe, and P.U. Cameron. 1998. HIV-1 selection by epi-
dermal dendritic cells during transmission across human skin.
J. Exp. Med. 187:1623–1631.
39. Pope, M., M.G.H. Betjes, N. Romani, P.U. Cameron, L.
Hoffman, S. Gezelter, G. Schuler, and R.M. Steinman. 1994.
Conjugates of dendritic cells and memory T lymphocytes
from skin facilitate productive infection with HIV-1. Cell.
78:389–398.
40. Steinman, R., L. Hoffman, and M. Pope. 1995. Maturation1500 Microbicides Block HIV Infection of Langerhans Cells within Tissue
and migration of cutaneous dendritic cells. J. Invest. Dermatol.
105:2S–7S.
41. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig,
C.R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and
coordinated switch in chemokine receptor expression during
dendritic cell maturation. Eur. J. Immunol. 28:2760–2769.
42. Kruse, M., O. Rosorius, F. Kratzer, G. Stelz, C. Kuhnt, G.
Schuler, J. Hauber, and A. Steinkasserer. 2000. Mature den-
dritic cells infected with herpes simplex virus type 1 exhibit
inhibited T-cell stimulatory capacity. J. Virol. 74:7127–7136.
43. Zhang, Z.Q., T. Schuler, M. Zupancic, S. Wietgrefe, K.A.
Staskus, K.A. Reimann, T.A. Reinhart, M. Rogan, W.
Cavert, C.J. Miller, et al. 1999. Sexual transmission and
propagation of SIV and HIV in resting and activated CD4(1)
T cells. Science. 286:1353–1357.
44. Granelli-Piperno, A., M. Pope, K. Inaba, and R.M. Stein-
man. 1995. Coexpression of NF-kappa B/Rel and Sp1 tran-
scription factors in human immunodeficiency virus 1-induced,
dendritic cell-T-cell syncytia. Proc. Natl. Acad. Sci. USA. 92:
10944–10948.
45. Spira, A.I., P.A. Marx, B.K. Patterson, J. Mahoney, R.A.
Koup, S.M. Wolinsky, and D.D. Ho. 1996. Cellular targets
of infection and route of viral dissemination after an intravag-
inal inoculation of simian immunodeficiency virus into
rhesus macaques. J. Exp. Med. 183:215–225.
46. Stahl-Hennig, C., R.M. Steinman, K. Tenner-Racz, M.
Pope, N. Stolte, K. Matz-Rensing, G. Grobschupff, B. Rasch-
dorff, G. Hunsmann, and P. Racz. 1999. Rapid infection of
oral mucosal-associated lymphoid tissue with simian immu-
nodeficiency virus. Science. 285:1261–1265.
47. Granelli-Piperno, A., B. Moser, M. Pope, D. Chen, Y. Wei,
F. Isdell, U. O’Doherty, W. Paxton, R. Koup, S. Mojsov, et
al. 1996. Efficient interaction of HIV-1 with purified den-
dritic cells via multiple chemokine coreceptors. J. Exp. Med.
184:2433–2438.
48. Blauvelt, A., H. Asada, M.W. Saville, V. Klaus-Kovtun, D.J.
Altman, R. Yarchoan, and S.I. Katz. 1997. Productive infec-
tion of dendritic cells by HIV-1 and their ability to capture
virus are mediated through separate pathways. J. Clin. Invest.
100:2043–2053.
49. Hu, J., M.B. Gardner, and C.J. Miller. 2000. Simian immu-
nodeficiency virus rapidly penetrates the cervicovaginal mu-
cosa after intravaginal inoculation and infects intraepithelial
dendritic cells. J. Virol. 74:6087–6095.
50. Phillips, D.M., X. Tan, R. Pearce-Pratt, and V.R. Za-
charopoulos. 1995. An assay for HIV infection of cultured
human cervix-derived cells. J. Virol. Methods. 52:1–13.
51. Wu, S.J.L., G. Grouard-Vogel, W. Sun, J.R. Mascola, E.
Brachtel, R. Putvatana, M.K. Louder, L. Filgueira, M.A.
Marovich, H.K. Wong, et al. 2000. Human skin Langerhans
cells are targets of dengue virus infection. Nat. Med. 6:816–
820.